The table below shows HAEMONETICS CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Operating cash flow
$293.22M
$181.72M
$181.75M
$273.06M
$172.26M
$108.81M
Capital expenditure
$32.78M
$39.28M
$38.13M
$191.33M
$96.51M
$37.04M
Investing cash flow
-$179.55M
-$161.90M
-$322.39M
-$143.79M
-$86.34M
-$425.44M
Dividends paid
-
-
-
-
-
HAE operating cash flow (10-K history)
HAEMONETICS CORP reported operating cash flow of $293.22M for fiscal year 2026. That is up 61.4% from $181.72M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $159.74M (FY 2017) to $293.22M. Figures come from the company's audited annual reports as filed with the SEC.
